Omnicell Inc (OMCL) support and resistance · P/E 90, rev $1.11B
Omnicell Inc (OMCL) is a health information services company listed on NASDAQ.
This page maps Omnicell Inc (OMCL) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported OMCL revenue for 2024-12-31 was $1.11B. Net income was $12.5M. Revenue was down 3.0% from 2023-12-31 to 2024-12-31. OMCL currently screens at market cap $1.80B and trailing P/E 89.9.
OMCL currently screens at market cap $1.80B and trailing P/E 89.9. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new OMCL 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the OMCL quote page for the session range and the stock page for the full model.
Not investment advice.